HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

VXA-CoV2-1.1-S vaccine

oral tableted Ad5 COVID-19 vaccine containing E1-/E3-deleted replication defective recombinant adenovirus 5 with dsRNA adjuvant

Also Known As:

VXA-CoV2-1.1-S; VXA-CoV2-1.1-S COVID-19 vaccine

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Synthetic Vaccines: 1073
      - VXA-CoV2-1.1-S vaccine
    - Viral Vaccines: 462
      - COVID-19 Vaccines: 7607
        VXA-CoV2-1.1-S vaccine
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Recombinant Proteins: 2754
    - Synthetic Vaccines: 1073
      - VXA-CoV2-1.1-S vaccine
Biological Factors: 2472
- Antigens: 143924
  - Synthetic Vaccines: 1073
    - VXA-CoV2-1.1-S vaccine